Composition

LETROZOLE 2.5mg Film-Coated Tablets x 30.

Indications

Breast cancer with hormone receptor positivity in postmenopausal patients.

Metastatic breast cancer with hormone receptor positivity or unknown status in postmenopausal patients.

Advanced breast cancer in postmenopausal patients with disease progression after anti-estrogen therapy.

Presentations

2.5mg Film-Coated Tablets x 30.